Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jost

Showing results (251-260 of 384) with videos related to

Pageof 39
Sort By:
Sleep Medicine Clinics|September 5, 2025
The Glymphatic System and Sleep Dysfunction in Parkinson's DiseaseDaniele Urso, Valentina Gnoni, Eleonora Rollo, et al.
Neurology|June 16, 2005
A new botulinum toxin type A free of complexing proteins for treatment of cervical dystoniaR Benecke, W H Jost, P Kanovsky, et al.
Fortschritte Der Neurologie-Psychiatrie|March 3, 2010
[When should we start medical treatment in Parkinson disease]C Buhmann, J Klucken, A Korchounov, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 2, 2002
Argus: a new instrument for the measurement of the stratospheric dynamical tracers, N2O and CH4Max Loewenstein, H Jost, J Grose, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 12, 2010
Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's diseaseEdna Grünblatt, Sonja Zehetmayer, Christian P Jacob, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|January 14, 2018
OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized TrialTheodore Wein, Alberto Esquenazi, Wolfgang H Jost, et al.
Toxins|January 27, 2026
Neurophysiological Assessment of F-Wave, M-Wave, and Cutaneous Silent Period in Patients with Caput-Pattern Cervical Dystonia at Waning and Peak Response Phases of Botulinum Toxin TherapyArtur Drużdż, Edyta Leśniewska-Furs, Małgorzata Dudzic, et al.
Neurological Research and Practice|May 11, 2025
Real-world disease burden and planned treatment optimization after MANAGE-PD implementation in Germany: a cross-sectional studyMartin Südmeyer, David J Pedrosa, Frank Siebecker, et al.
Current Medical Research and Opinion|July 8, 2023
Real world data of a German Parkinson's disease population: effectiveness and safety of safinamide in routine clinical practiceWolfgang H Jost, Ivonne Gluth, Jennifer C Lück, et al.
Neurological Research and Practice|March 16, 2022
Characterization of advanced Parkinson's disease in Germany: results of the non-interventional OBSERVE-PD studyDavid J Pedrosa, Florin Gandor, Wolfgang H Jost, et al.
Pageof 39

Showing results (251-260 of 384) with videos related to

Sort By:
Pageof 39
Sleep Medicine Clinics|September 5, 2025
The Glymphatic System and Sleep Dysfunction in Parkinson's DiseaseDaniele Urso, Valentina Gnoni, Eleonora Rollo, et al.
Neurology|June 16, 2005
A new botulinum toxin type A free of complexing proteins for treatment of cervical dystoniaR Benecke, W H Jost, P Kanovsky, et al.
Fortschritte Der Neurologie-Psychiatrie|March 3, 2010
[When should we start medical treatment in Parkinson disease]C Buhmann, J Klucken, A Korchounov, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 2, 2002
Argus: a new instrument for the measurement of the stratospheric dynamical tracers, N2O and CH4Max Loewenstein, H Jost, J Grose, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 12, 2010
Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's diseaseEdna Grünblatt, Sonja Zehetmayer, Christian P Jacob, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|January 14, 2018
OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized TrialTheodore Wein, Alberto Esquenazi, Wolfgang H Jost, et al.
Toxins|January 27, 2026
Neurophysiological Assessment of F-Wave, M-Wave, and Cutaneous Silent Period in Patients with Caput-Pattern Cervical Dystonia at Waning and Peak Response Phases of Botulinum Toxin TherapyArtur Drużdż, Edyta Leśniewska-Furs, Małgorzata Dudzic, et al.
Neurological Research and Practice|May 11, 2025
Real-world disease burden and planned treatment optimization after MANAGE-PD implementation in Germany: a cross-sectional studyMartin Südmeyer, David J Pedrosa, Frank Siebecker, et al.
Current Medical Research and Opinion|July 8, 2023
Real world data of a German Parkinson's disease population: effectiveness and safety of safinamide in routine clinical practiceWolfgang H Jost, Ivonne Gluth, Jennifer C Lück, et al.
Neurological Research and Practice|March 16, 2022
Characterization of advanced Parkinson's disease in Germany: results of the non-interventional OBSERVE-PD studyDavid J Pedrosa, Florin Gandor, Wolfgang H Jost, et al.
Pageof 39